Acute disseminated encephalomyelitis

Neurology

Volumn 68, Issue 16 SUPPL. 2, 2007, Pages

  Tenembaum, Silvia ^a   Chitnis, Tanuja ^b   Ness, Jayne ^c   Hahn, Jin S ^d  

^a Dr Juan P Garrahan   (Argentina)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; AZATHIOPRINE; BETA INTERFERON; CHICKENPOX VACCINE; CORTICOSTEROID; CORTICOTROPIN; CYCLOPHOSPHAMIDE; CYTOSTATIC AGENT; DEXAMETHASONE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; GLATIRAMER; HEPATITIS B VACCINE; IMMUNOGLOBULIN; INFLUENZA VACCINE; JAPANESE ENCEPHALITIS VACCINE; MEASLES VACCINE; METHYLPREDNISOLONE; MUMPS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; PREDNISONE; RABIES VACCINE; RADIOPHARMACEUTICAL AGENT; RUBELLA VACCINE; SMALLPOX VACCINE; STEROID;

BLOOD PRESSURE; CLINICAL FEATURE; DEMOGRAPHY; DEMYELINATING DISEASE; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE MARKER; DRUG DOSE REDUCTION; DRUG FATALITY; DRUG MEGADOSE; ENCEPHALITIS; ENCEPHALOMYELITIS; FLUSHING; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERGLYCEMIA; HYPOKALEMIA; MOOD DISORDER; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATHOGENESIS; PELIZAEUS MERZBACHER DISEASE; PRIORITY JOURNAL; RADIODIAGNOSIS; RECURRENT DISEASE; REVIEW; SIDE EFFECT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPINAL CORD; STOMACH PERFORATION; WHITE MATTER;

EID: 34247202185     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000259404.51352.7f     Document Type: Article

References (158)

1. Rust RS. Multiple sclerosis, acute disseminated encephalomyelitis, and related conditions. Semin Pediatr Neurol 2000;7:66-90.
2. Dale RC. Acute disseminated encephalomyelitis. Semin Pediatr Infect Dis 2003;14:90-95.
3. Garg RK. Acute disseminated encephalomyelitis. Postgrad Med J 2003;79:11-17.
4. Jones CT. Childhood autoimmune neurologic diseases of the central nervous system. Neurol Clin 2003;21:745-764.
5. Marsden JP, Hurst EW. Acute perivascular myelinoclasis ("acute disseminated encephalomyelitis") in smallpox. Brain 1932;55:181-193.
6. Davison C, Brock S. Acute demyelinating encephalomyelitis following respiratory disease. Bull Neurol Inst NY 1937;6:504-514.
7. Van Bogaert L. Post-infectious encephalomyelitis and multiple sclerosis; the significance of perivenous encephalomyelitis. J Neuropathol Exp Neurol 1950;9:219-249.
8. Ferraro A, Roizin L. Hyperergic encephalomyelitides following exanthematic diseases, infectious diseases and vaccination. J Neuropathol Exp Neurol 1957;16:423-445.
9. DeVries. Postvaccinal perivenous encephalitis. Amsterdam: Elsevier, 1960.
10. Carpenter S, Lampert PW. Postinfectious perivenous encephalitis and acute hemorrhagic leukoencephalitis. In: Minckler J, ed. Pathology of the nervous system. New York: McGraw-Hill, 1968:2260-2269.
11. Poser ChM. Disseminated vasculomyelinopathy. A review of the clinical and pathologic reactions of the nervous system in hyperergic diseases. Acta Neurol Scand 1969:37 suppl:33-44.
12. Pasternak JF, De Vivo DC, Prensky AL. Steroid responsive encephalomyelitis in childhood. Neurology 1980;30:481-486.
13. Lukes SA, Norman D. Computed tomography in acute disseminated encephalomyelitis. Ann Neurol 1983;13:567-572.
14. Dunn V, Bale JF, Zimmerman RA, Perdue Z, Bell WE. MRI in children with postinfectious disseminated encephalomyelitis. Magn Reson Imaging 1986;4:25-32.
15. Boulloche J, Parain D, Mallet E, Tron P. Postinfectious encephalitis with multifocal white matter lesions. Neuropediatrics 1989;20:173-175.
16. Brinar VV. Non-MS recurrent demyelinating diseases. Clin Neurol Neurosurg 2004;106:197-210.
17. Schwarz S, Mohr A, Knauth M, Wildemann B, Storch-Agenlocher B. Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology 2001;56:1313-1318.
18. Dale RC, de Sousa C, Chong WK, Cox TC, Harding B, Neville BG. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain 2000;123:2407-2422.
19. Leake JAD, Albani S, Kao AS, et al. Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features. Pediatr Infect Dis J 2004;23:756-764.
20. Murthy KSN, Faden HS, Cohen ME, Bakshi R. Acute disseminated encephalomyelitis in children. Pediatrics 2002;110:21-28.
21. Tenembaum S, Chamoles N, Fejerman N. Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology 2002;59:1224-1231.
22. Hynson JL, Kornberg AJ, Coleman LT, Shield L, Harvey AS, Kean MJ. Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology 2001;56:1308-1312.
23. Anlar B, Basaran C, Kose G, et al. Acute disseminated encephalomyelitis in children: outcome and prognosis. Neuropediatrics 2003;34:194-199.
24. Amit R, Shapira Y, Blank A, Aker M. Acute, severe, central and peripheral nervous system combined demyelination. Pediatr Neurol 1986;2:47-50.
25. Menge T, Hemmer B, Nessler S, et al. Acute disseminated encephalomyelitis. An update. Arch Neurol 2005;62:1673-1680.
26. Gupte G, Stonehouse M, Wassmer E, Coad NA, Whitehouse WP. Acute disseminated encephalomyelitis: a review of 18 cases in childhood. J Paediatr Child Health 2003;39:336-342.
27. Amit R, Glick B, Itzchak Y, Dgani Y, Meyeir S. Acute severe combined demyelination. Child's Nerv Syst 1992;8:354-356.
28. Nadkarni N, Lisak R. Guillain-Barré syndrome (GBS) with bilateral optic neuritis and central white matter disease. Neurology 1993;43:842-843.
29. Marchioni E, Ravaglia S, Piccolo G, et al. Postinfectious inflammatory disorders: subgroups based on prospective follow-up. Neurology 2005;65:1057-1065.
30. Wingerchuk DM. Postinfectious encephalomyelitis. Curr Neurol Neurosci Rep 2003;3:256-264.
31. Baum PA, Barkovich AJ, Koch TK, Berg BO. Deep grey matter involvement in children with acute disseminating encephalomyelitis. AJNR Am J Neuroradiol 1994;15:1275-1283.
32. Kimura S, Unayama T, Mori T. The natural history of acute disseminated leukoencephalitis. A serial magnetic resonance imaging study. Neuropediatrics 1992;23:192-195.
33. Kesselring J, Miller DH, Robb SA, et al. Acute disseminated encephalomyelitis and MRI findings and the distinction from multiple sclerosis. Brain 1990;113:291-302.
34. Singh S, Alexander M, Korah IP. Acute disseminated encephalomyelitis: MR imaging features. AJR Am J Roentgenol 1999;173:1101-1107.
35. Khong PL, Ho HK, Cheng PW, Wong VC, Goh W, Chan FL. Childhood acute disseminated encephalomyelitis: the role of brain and spinal cord MRI. Pediatr Radiol 2002;32:59-66.
36. Lim KE, Hsu YY, Hsu WC, Chan CY. Multiple complete ring-shaped enhanced MRI lesions in disseminated encephalomyelitis. Clin Imaging 2003;27:281-284.
37. Caldemeyer KS, Smith RR, Harris TM, Edwards MK. MRI in acute disseminated encephalomyelitis. Neuroradiology 1994;36:216-220.
38. Van Meyden CH, de-Villers JFK, Middlecote BD, Terbalanche J. Gadolinium ring enhancement and mass effect in acute disseminating encephalomyelitis. Neuroradiol 1994;36:221-223.
39. Mikaeloff Y, Suissa S, Vallée L, et al. First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability. J Pediatr 2004;144:246-252.
40. Richer LR, Sinclair DB, Bhargava R. Neuroimaging features of acute disseminated encephalomyelitis in childhood. Pediatr Neurol 2005;32:30-36.
41. Bizzi A, Ulug AM, Crawford TO, et al. Quantitative proton MR spectroscopic imaging in acute disseminated encephalomyelitis. AJNR Am J Neuroradiol 2001;22:1125-1130.
42. Mader I, Wolff M, Nagele T, Niemann G, Grodd W, Kuker W. MRI and proton MR spectroscopy in acute disseminated encephalomyelitis. Childs Nerv Syst 2005;21:566-572.
43. Harada M, Hisaoka S, Mori K, Yoneda K, Noda S, Nishitani H. Differences in water diffusion and lactate production in two different types of postinfectious encephalopathy. J Magn Reson Imaging 2000;11:559-563.
44. Bernarding J, Braun J, Koennecke HC. Diffusion- and perfusion-weighted MR imaging in a patient with acute disseminated encephalomyelitis (ADEM). J Magn Reson Imaging 2002;15:96-100.
45. Tabata K, Shishido F, Uemura K, et al. Positron emission tomography in acute disseminated encephalomyelitis: a case report. Kaku Igaku 1990;27:261-265.
46. Broich K, Horwich D, Alavi A. HMPAO-SPECT and MRI in acute disseminated encephalomyelitis. J Nucl Med 1991;32:1897-1900.
47. San Pedro EC, Mountz JM, Liu HG, Deutsch G. Postinfectious cerebellitis: clinical significance of Tc-99m HMPAO brain SPECT compared with MRI. Clin Nucl Med 1998;23:212-216.
48. Itti E, Huff K, Cornford ME, Itti L, Poruri K, Mishkin FS. Postinfectious encephalitis. A coregistered SPECT and magnetic resonance imaging study. Clin Nucl Med 2002;27:129-130.
49. Okamoto M, Ashida KI, Imaizumi M. Hypoperfusion following encephalitis: SPECT with acetazolamide. Eur J Neurol 2001;8:471-474.
50. Hahn CD, Miles BS, MacGregor DL, Blaser SI, Banwell BL, Hetherington CR. Neurocognitive outcome after acute disseminated encephalomyelitis. Pediatr Neurol 2003;29:117-123.
51. Hung K-L, Liao H-T, Tsai M-L. The spectrum of postinfectious encephalomyelitis. Brain Dev 2001;23:42-45.
52. Tardieu M, Mikaeloff Y. What is acute disseminated encephalomyelitis (ADEM)? Eur J Paediatr Neurol 2004;8:239-242.
53. Seales D, Greer M. Acute hemorrhagic leukoencephalitis: a successful recovery. Arch Neurol 1991;48:1086-1088.
54. Rosman PN, Gottlieb SM, Bernstein CA. Acute hemorrhagic leukoencephalitis: recovery and reversal of magnetic resonance imaging findings in a child. J Child Neurol 1997;12:448-454.
55. Klein C, Wijdicks EFM, Earnest IVF. Full recovery after acute hemorrhagic leukoencephalitis (Hurst's disease). J Neurol 2000;247:977-979.
56. Kuperan S, Ostrow P, Landi MK, Bakshi R. Acute hemorrhagic leukoencephalitis vs. ADEM: FLAIR MRI and neuropathology findings. Neurology 2003;60:721-722.
57. Mader I, Wolff M, Niemann G, Küker W. Acute haemorrhagic encephalomyelitis (AHEM): MRI findings. Neuropediatrics 2004;35:143-146.
58. Miller DH, Scaravilli F, Thomas DCT, Harvey P, Hirsch NP. Acute disseminated encephalomyelitis presenting as a solitary brainstem mass. J Neurol Neurosurg Psychiatry 1993;56:920-922.
59. Tateishi K, Takeda K, Mannen T. Acute disseminated encephalomyelitis confined to brainstem. J Neuroimaging 2002;12:67-68.
60. Firat AK, Karakas HM, Yakinci C, Altinok T, Alkan A, Biçak U. An unusual case of acute disseminated encephalomyelitis confined to brainstem. Magn Reson Imaging 2004;22:1329-1332.
61. Straussberg R, Schonfeld T, Weitz R, Karmazyn B, Harel L. Improvement of atypical acute disseminated encephalomyelitis with steroids and intravenous immunoglobulins. Pediatr Neurol 2001;24:139-143.
62. Garg BP, Kleiman MB. Acute disseminated encephalomyelitis presenting as a neurodegenerative disease in infancy. Pediatr Neurol 1994;11:57-58.
63. van der Knaap MS, Valk J. Myelination and retarded myelination. In: van der Knaap MS, Valk J, eds. Magnetic resonance of myelin, myelination, and myelin disorders. 2nd ed. Berlin-Heidelberg: Springer-Verlag, 1995:31-52.
64. Ramaswamy V, Sinclair DB, Wheatley BM, Richer L, Snyder T. Epilepsia partialis continua: acute disseminated encephalomyelitis or Rasmussen's encephalitis? Pediatr Neurol 2005;32:341-345.
65. Shoji H, Kusuhara T, Honda Y, et al. Relapsing acute disseminated encephalomyelitis associated with chronic Epstein-Barr virus infection: MRI findings. Neuroradiology 1992;34:340-342.
66. Khan S, Yaqub BA, Poser CMAL, Deeb SM, Bohlega S. Multiphasic disseminated encephalomyelitis presenting as alternating hemiplegia. J Neurol Neurosurg Psychiatry 1995;58:467-470.
67. Tsai M-L, Hung K-L. Multiphasic disseminated encephalomyelitis mimicking multiple sclerosis. Brain Dev 1996;18:412-414.
68. Hahn JS, Siegler DJ, Enzmann D. Intravenous gammaglobulin therapy in recurrent acute disseminated encephalomyelitis. Neurology 1996;46:1173-1174.
69. Apak RA, Anlar B, Saatci I. A case of relapsing acute disseminated encephalomyelitis with high dose corticosteroid treatment. Brain Dev 1999;21:279-282.
70. Revel-Vilk S, Hurvitz H, Klar A, Virozov Y, Korn-Lubetzki I. Recurrent acute disseminated encephalomyelitis associated with acute cytomegalovirus and Epstein-Barr virus infection. J Child Neurol 2000;15:421-424.
71. Cohen O, Steiner-Birmanns B, Biran I, Abramsky O, Honigman S, Steiner I. Recurrence of acute disseminated encephalomyelitis at the previously affected brain site. Arch Neurol 2001;58:797-801.
72. Härtel C, Schilling S, Gottschalk S, Sperner J. Multiphasic disseminated encephalomyelitis associated with streptococcal infection. Eur J Paediatr Neurol 2002;6:327-329.
73. Mariotti P, Batocchi AP, Colosimo C, et al. Multiphasic demyelinating disease involving central and peripheral nervous system in a child. Neurology 2003;60:348-349.
74. Alper G, Schor NF. Toward the definition of acute disseminated encephalitis of childhood. Curr Opin Pediatr 2004;16:637-640.
75. 74a. Krupp LB, Banwell B, Tenembaum S, for the International Pediatric MS Study Group. Consensus definitions proposed for pediatric multiple sclerosis and related childhood disorders. Neurology 2007;68(suppl 2):S7-S12.
76. Poser CM, Goutières F, Carpentier MA, Aicardi J. Shilder's myelinoclastic diffuse sclerosis. Pediatrics 1986;77:107-112.
77. Kepes JJ. Large focal tumor-like demyelinating lesions of the brain: intermediate entity between MS and acute disseminated encephalomyelitis? A study of 31 patients. Ann Neurol 1993;33:18-27.
78. Tenembaum S, Galicchio S, Grañana N, et al. Demyelinating encephalopathies with large focal lesions: diagnostic clues. Brain Dev 1998;20:434. Abstract.
79. Mizuguchi M, Abe J, Mikkaichi K, et al. Acute necrotizing encephalopathy of childhood: a new syndrome presenting with multifocal, symmetric brain lesions. J Neurol Neurosurg Psychiatry 1995;58:555-561.
80. Mizuguchi M. Acute necrotizing encephalopathy of childhood: a novel form of acute encephalopathy prevalent in Japan and Taiwan. Brain Dev 1997;19:81-92.
81. Suwa K, Yamagata T, Momoi MT, et al. Acute relapsing encephalopathy mimicking acute necrotizing encephalopathy in a 4-year-old boy. Brain Dev 1999;21:554-558.
82. Ruggieri M, Polizzi A, Pavone L, Musumeci S. Thalamic syndrome in children with measles infection and selective, reversible thalamic involvement. Pediatrics 1998;101:112-119.
83. Hartfield D, Loewy J, Yager J. Transient thalamic changes on MRI in a child with hypernatremia. Pediatr Neurol 1999;20:60-62.
84. Ohtaki E, Murakami Y, Komori H, et al. Acute disseminated encephalomyelitis after Japanese B encephalitis vaccination. Pediatr Neurol 1992;8:137-139.
85. Cusmai R, Bertini E, Di Capua M, et al. Bilateral, reversible, selective thalamic involvement demonstrated by brain MR and acute severe neurological dysfunction with favorable outcome. Neuropediatrics 1994;25:44-47.
86. Goutières F, Aicardi J. Acute neurological dysfunction associated with destructive lesions of the basal ganglia in children. Ann Neurol 1982;12:328-332.
87. Dale RC, Church AJ, Cardoso F, et al. Post streptococcal acute disseminated encephalomyelitis with basal ganglia Involvement and autoreactive antibasal ganglia antibodies. Ann Neurol 2001;50:588-595.
88. Miller HG, Gibbons JL. Acute disseminated encephalomyelitis and acute disseminated sclerosis; results of treatment with A.C.T.H. BMJ 1953;4850:1345-1348.
89. Ziegler DK. Acute disseminated encephalomyelitis. Arch Neurol 1966;14:476-488.
90. Shahar E, Andraus J, Savitzki D, Pilar G, Zelnik N. Outcome of severe encephalomyelitis in children: effect of high-dose methylprednisolone and immunoglobulins. J Child Neurol 2002;17:810-814.
91. Kotlus BS, Slavin ML, Guthrie DS, Kodsi SR. Ophthalmologic manifestations in pediatric patients with acute disseminated encephalomyelitis. J AAPOS 2005;9:179-183.
92. Thomas GS, Hussain IH. Acute disseminated encephalomyelitis: a report of six cases. Med J Malaysia 2004;59:342-351.
93. Nishikawa M, Ichiyama T, Hayashi T, Ouchi K, Furukawa S. Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis. Pediatr Neurol 1999;21:583-586.
94. Kleiman M, Brunquell P. Acute disseminated encephalomyelitis: response to intravenous immunoglobulin. J Child Neurol 1995;10:481-483.
95. Sahlas DJ, Miller SP, Guerin M, Veilleux M, Francis G. Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin. Neurology 2000;54:1370-1372.
96. Pradhan S, Gupta RP, Shashank S, Pandey N. Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis. J Neurol Sci 1999;165:56-61.
97. Marchioni E, Marinou-Aktipi K, Uggetti C, et al. Effectiveness of intravenous immunoglobulin treatment in adult patients with steroidresistant monophasic or recurrent acute disseminated encephalomyelitis. J Neurol 2002;249:100-104.
98. Pittock SJ, Keir G, Alexander M, Brennan P, Hardiman O. Rapid clinical and CSF response to intravenous gamma globulin in acute disseminated encephalomyelitis. Eur J Neurol 2001;8:725.
99. Keegan M, Pineda AA, McClelland RL, Darby CH, Rodriguez M, Weinshenker BG. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 2002;58:143-146.
100. Stricker RB, Miller RG, Kiprov DD. Role of plasmapheresis in acute disseminated (postinfectious) encephalomyelitis. J Clin Apheresis 1992;7:173-179.
101. Ramachandrannair R, Rafeequ M, Girija AS. Plasmapheresis in childhood acute disseminated encephalomyelitis. Ind Pediatr 2005;42:479-482.
102. Miyazawa R, Hikima A, Takano Y, Arakawa H, Tomomasa T, Morikawa A. Plasmapheresis in fulminant acute disseminated encephalomyelitis. Brain Dev 2001;23:424-426.
103. Balestri P, Grosso S, Acquaviva A, Bernini M. Plasmapheresis in a child affected by acute disseminated encephalomyelitis. Brain Dev 2000;22:123-126.
104. Newton R. Plasma exchange in acute post-infectious demyelination. Dev Med Child Neurol 1981;23:538-543.
105. Lin CH, Jeng JS, Yip PK. Plasmapheresis in acute disseminated encephalomyelitis. J Clin Apheresis 2004;19:154-159.
106. Kimura S, Nezu A, Ohtsuki N, Kobayashi T, Osaka H, Uehara S. Serial magnetic resonance imaging in children with postinfectious encephalitis. Brain Dev 1996;18:461-465.
107. Murthy JM, Yangala R, Meena AK, Jaganmohan RJ. Acute disseminated encephalomyelitis: clinical and MRI study from South India. J Neurol Sci 1999;165:133-138.
108. Idrissova Z, Boldyreva MN, Dekonenko EP, et al. Acute disseminated encephalomyelitis in children: clinical features and HLA-DR linkage. Eur J Neurol 2003;10:537-546.
109. Jacobs RK, Anderson VA, Neale JL, Shield LK, Kornberg AJ. Neuropsychological outcome after acute disseminated encephalomyelitis: impact of age at illness onset. Pediatr Neurol 2004;31:191-197.
110. Banwell BL, Anderson PE. The cognitive burden of multiple sclerosis in children. Neurology 2005;64:891-894.
111. Morimatsu M. Recurrent ADEM or MS? Intern Med 2004;43:647-648.
112. Pohl D, Rostasy K, Reiber H, Hanefeld F. CSF characteristics in earlyonset multiple sclerosis. Neurology 2004;63:1966-1967.
113. Mikaeloff Y, Adamsbaum C, Husson B, et al. MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain 2004;127:1942-1947.
114. Tardieu M, Mikaeloff Y. Multiple sclerosis in children. Int MS J 2004;11:36-42.
115. Rudick RA, Goodman A, Herndon RM, Panitch HS. Selecting relapsing remitting multiple sclerosis patients for treatment: the case for early treatment. J Neuroimmunol 1999;98:22-28.
116. Coyle PK, Hartung HP. Use of interferon beta in multiple sclerosis: rationale for early treatment and evidence for dose- and frequencydependent effects on clinical response. Mult Scler 2002;8:2-9.
117. Pohl D, Rostasy K, Gärtner J, Hanefeld F. Treatment of early onset multiple sclerosis with subcutaneous interferon beta-1a. Neurology 2005;64:888-890.
118. Tenembaum SN, Segura MJ. Interferon beta-1a treatment in childhood and juvenile-onset multiple sclerosis. Neurology 2006;67:511-513.
119. Ghosh N, DeLuca GC, Esiri MM. Evidence of axonal damage in human acute demyelinating diseases. J Neurol Sci 2004;222:29-34.
120. DeLuca GC, Ebers GC, Esiri MM. Axonal loss in multiple sclerosis: a pathological survey of the corticospinal and sensory tracts. Brain 2004;127:1009-1018.
121. Ichiyama T, Shoji H, Kato M, et al. Cerebrospinal fluid levels of cytokines and soluble tumour necrosis factor receptor in acute disseminated encephalomyelitis. Eur J Pediatr 2002;161:133-137.
122. Dale RC, Morovat A. Interleukin-6 and oligoclonal IgG synthesis in children with acute disseminated encephalomyelitis. Neuropediatrics 2003;34:141-145.
123. Kumar V, Cotran RS, Robbins SL. Robbins basic pathology, updated edition. 7th ed. Saunders; 2004.
124. Horowitz MB, Comey C, Hirsch W, Marion D, Griffith B, Martinez J. Acute disseminated encephalomyelitis (ADEM) or ADEM-like inflammatory changes in a heart-lung transplant recipient: a case report. Neuroradiology 1995;37:434-437.
125. Re A, Giachetti R. Acute disseminated encephalomyelitis (ADEM) after autologous peripheral blood stem cell transplant for non-Hodgkin's lymphoma. Bone Marrow Transplant 1999;24:1351-1354.
126. Iwanaga T, Ooboshi H, Imamura T, et al. A case of acute disseminated encephalomyelitis after renal transplantation. Rinsho Shinkeigaku 2001;41:792-796.
127. Au WY, Lie AK, Cheung RT, et al. Acute disseminated encephalomyelitis after para-influenza infection post bone marrow transplantation. Leuk Lymphoma 2002;43:455-457.
128. Tomonari A, Tojo A, Adachi D, et al. Acute disseminated encephalomyelitis (ADEM) after allogeneic bone marrow transplantation for acute myeloid leukemia. Ann Hematol 2003;82:37-40.
129. Hemachudha T, Griffin DE, Giffels JJ, Johnson RT, Moser AB, Phanuphak P. Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination. N Engl J Med 1987;316:369-374.
130. Hemachudha T, Griffin DE, Johnson RT, Giffels JJ. Immunologic studies of patients with chronic encephalitis induced by post-exposure Semple rabies vaccine. Neurology 1988;38:42-44.
131. Murthy JM. Acute disseminated encephalomyelitis. Neurol India 2002;50: 238-243.
132. Fenichel GM. Neurological complications of immunization. Ann Neurol 1982;12:119-128.
133. Takahashi H, Pool V, Tsai TF, Chen RT. Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States. The VAERS Working Group. Vaccine 2000;18:2963-2969.
134. Tourbah A, Gout O, Liblau R, et al. Encephalitis after hepatitis B vaccination: recurrent disseminated encephalitis or MS? Neurology 1999;53:396-401.
135. Karaali-Savrun F, Altintas A, Saip S, Siva A. Hepatitis B vaccine related-myelitis? Eur J Neurol 2001;8:711-715.
136. Sejvar JJ, Labutta RJ, Chapman LE, Grabenstein JD, Iskander J, Lane JM. Neurologic adverse events associated with smallpox vaccination in the United States, 2002-2004. JAMA 2005;294:2744-2750.
137. Ozawa H, Noma S, Yoshida Y, Sekine H, Hashimoto T. Acute disseminated encephalomyelitis associated with poliomyelitis vaccine. Pediatr Neurol 2000;23:177-179.
138. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995;80:695-705.
139. Clatch RJ, Lipton HL, Miller SD. Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs. J Immunol 1986;136:920-927.
140. Rodriguez M, Pavelko KD, Njenga MK, Logan WC, Wettstein PJ. The balance between persistent virus infection and immune cells determines demyelination. J Immunol 1996;157:5699-5709.
141. Miller SD, Vanderlugt CL, Begolka WS, et al. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat Med 1997;3:1133-1136.
142. Katz-Levy Y, Neville KL, Girvin AM, et al. Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice. J Clin Invest 1999;104:599-610.
143. McMahon EJ, Bailey SL, Castenada CV, Waldner H, Miller SD. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat Med 2005;11:335-339.
144. Tejada-Simon MV, Zang YC, Hong J, Rivera VM, Zhang JZ. Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis. Ann Neurol 2003;53:189-197.
145. Talbot PJ, Paquette JS, Ciurli C, Antel JP, Ouellet F. Myelin basic protein and human coronavirus 229E cross-reactive T cells in multiple sclerosis. Ann Neurol 1996;39:233-240.
146. Markovic-Plese S, Hemmer B, Zhao Y, Simon R, Pinilla C, Martin R. High level of cross-reactivity in influenza virus hemagglutinin-specific CD4+ T-cell response: implications for the initiation of autoimmune response in multiple sclerosis. J Neuroimmunol 2005;169:31-38.
147. Lang HL, Jacobsen H, Ikemizu S, et al. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol 2002;3:940-943.
148. Olson JK, Croxford JL, Miller SD. Virus-induced autoimmunity: potential role of viruses in initiation, perpetuation, and progression of T-cell-mediated autoimmune disease. Viral Immunol 2001;14:227-250.
149. Mokhtarian F, Zhang Z, Shi Y, Gonzales E, Sobel RA. Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice. J Neuroimmunol 1999;95:43-54.
150. Pohl-Koppe A, Burchett SK, Thiele EA, Hafler DA. Myelin basic protein reactive Th2 T cells are found in acute disseminated encephalomyelitis. J Neuroimmunol 1998;91:19-27.
151. Jorens PG, VanderBorght A, Ceulemans B, et al. Encephalomyelitis- associated antimyelin autoreactivity induced by streptococcal exotoxins. Neurology 2000;54:1433-1441.
152. O'Connor KC, Robinson WH, De-Jager PL, et al. High-throughput analysis of autoantibodies recognizing myelin antigens in acute disseminated encephalomyelitis. Neurology 2005;64(suppl 1):A417. Abstract.
153. Ubol S, Hemachudha T, Whitaker JN, Griffin DE. Antibody to peptides of human myelin basic protein in post-rabies vaccine encephalomyelitis sera. J Neuroimmunol 1990;26:107-111.
154. O'Connor KC, Chitnis T, Griffin DE, et al. Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions. J Neuroimmunol 2003;136:140-148.
155. Oh HH, Kwon SH, Kim CW, et al. Molecular analysis of HLA class II-associated susceptibility to neuroinflammatory diseases in Korean children. J Korean Med Sci 2004;19:426-430.
156. Stewart GJ, McLeod JG, Basten A, Bashir HV. HLA family studies and multiple sclerosis: a common gene, dominantly expressed. Hum Immunol 1981;3:13-29.
157. Haines JL, Ter-Minassian M, Bazyk A, et al. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group. Nat Genet 1996;13:469-471.
158. Boiko AN, Gusev EI, Sudomoina HA, et al. Association and linkage of juvenile MS with HLA-DR2(15) in Russians. Neurology 2002;58:658-660.